Side effects
Side effects as an overall problem
Side effects as an overall problem
Severity
Evaluations
Percentage
This item is relevant to you:
Severe
3
This item is relevant to you:
Moderate
6
This item is relevant to you:
Mild
5
This item is relevant to you:
None
7
Dosages
Based on patients currently taking Octreotide
Dosage
Patients
Percentage
This item is relevant to you:
20 mg monthly
1
Why patients stopped taking Octreotide
Multiple reasons could be selected
Reason
Patients
Percentage
This item is relevant to you:
Doctor's advice
5
This item is relevant to you:
Did not seem to work
3
This item is relevant to you:
Side effects too severe
2
This item is relevant to you:
Course of treatment ended
1
This item is relevant to you:
Expense
1
See
all
10 patients
who've
stopped taking Octreotide
Duration
Currently taking Octreotide
Duration
Patients
Percentage
This item is relevant to you:
10 years or more
1
Stopped taking Octreotide
Duration
Patients
Percentage
This item is relevant to you:
Less than 1 month
2
This item is relevant to you:
1 - 6 months
2
This item is relevant to you:
6 months - 1 year
2
This item is relevant to you:
1 - 2 years
1
This item is relevant to you:
2 - 5 years
2
This item is relevant to you:
5 - 10 years
1
This item is relevant to you:
10 years or more
1
Adherence
Adherence
Evaluations
Percentage
This item is relevant to you:
Always
20
20 evaluations from 17 patients
This item is relevant to you:
Usually
1
1 evaluation from 1 patient
This item is relevant to you:
Sometimes
0
0 evaluations from 0 patients
This item is relevant to you:
Never
taken as prescribed
0
0 evaluations from 0 patients
Burden
Burden
Evaluations
Percentage
This item is relevant to you:
Very
hard to take
0
0 evaluations from 0 patients
This item is relevant to you:
Somewhat
hard to take
7
7 evaluations from 7 patients
This item is relevant to you:
A little
hard to take
4
4 evaluations from 4 patients
This item is relevant to you:
Not at all
hard to take
10
10 evaluations from 9 patients
Cost per month
Cost per month
Evaluations
Percentage
This item is relevant to you:
$200+
5
5 evaluations from 3 patients
This item is relevant to you:
$100-199
2
2 evaluations from 2 patients
This item is relevant to you:
$50-99
0
0 evaluations from 0 patients
This item is relevant to you:
$25-49
1
1 evaluation from 1 patient
This item is relevant to you:
< $25
7
7 evaluations from 7 patients
This item is relevant to you:
Not specified
6
6 evaluations from 5 patients
What people switch to and from
Patients
started
taking
Octreotide
after stopping:
Treatment
Patients
Percentage
This item is relevant to you:
Cabergoline
(Dostinex )
1
This item is relevant to you:
Cyproheptadine
(Periactin )
1
This item is relevant to you:
Lanreotide
(Somatuline Depot )
1
This item is relevant to you:
Octreotide
(Sandostatin )
1
This item is relevant to you:
Temozolomide
(Temodar )
1
Patients
stopped
taking
Octreotide
and
switched to:
Treatment
Patients
Percentage
This item is relevant to you:
Lanreotide
(Somatuline Depot )
2
This item is relevant to you:
Chemotherapy
1
This item is relevant to you:
Diazoxide
1
This item is relevant to you:
Everolimus
(Afinitor )
1
This item is relevant to you:
Octreotide
(Sandostatin )
1
Last updated:
August 16, 2022